Mecasia, Rissa Mae .

HRN: 27-81-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFUROXIME 1.5GM (VIAL)
09/28/2025
09/29/2025
IV
1.5g
Q8hrs
PTOR
Checking Initial Appropriateness 
09/29/2025
MUPIROCIN 2%, 15G (TUBE)
09/29/2025
10/05/2025
TOPICAL
1ml
OD
SP LTCS
Checking Final Appropriateness 
10/02/2025
CEFUROXIME 500MG (TAB)
10/02/2025
10/08/2025
PO
500mg
2 Times A Day
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: